Prognostic Impact of Blood MN1 Copy Numbers Before Allogeneic Stem Cell Transplantation in Patients With Acute Myeloid Leukemia-Reference-Cited by-同舟云学术

Prognostic Impact of Blood MN1 Copy Numbers Before Allogeneic Stem Cell Transplantation in Patients With Acute Myeloid Leukemia

Published:2019-02 Issue:1 Volume:3 Page:e167
ISSN:2572-9241
Container-title:HemaSphere
language:en
Short-container-title:

Author:

Jentzsch Madlen,Bill Marius,Grimm Juliane,Schulz Julia,Beinicke Stefanie,Häntschel Janine,Goldmann Karoline,Pönisch Wolfram,Franke Georg-Nikolaus,Vucinic Vladan,Cross Michael,Behre Gerhard,Lange Thoralf,Niederwieser Dietger,Schwind Sebastian

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Hematology

Reference43 articles.

1. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia;N Engl J Med.,2013

2. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel;Döhner;Blood.,2017

3. Acute myeloid leukemia;Döhner;N Engl J Med.,2015

4. Assessment of minimal residual disease in standard-risk AML;Ivey;N Engl J Med.,2016

5. Measurable residual disease testing in acute myeloid leukaemia;Hourigan;Leukemia.,2017

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular MRD Assessment in Acute Myeloid Leukemias;Indian Journal of Medical and Paediatric Oncology;2023-04-17

2. Current and Emerging Techniques for Diagnosis and MRD Detection in AML: A Comprehensive Narrative Review;Cancers;2023-02-21

3. Impact of IDH1 and IDH2 mutation detection at diagnosis and in remission in patients with AML receiving allogeneic transplantation;Blood Advances;2023-02-03

4. Prognostic impact of the AML ELN2022 risk classification in patients undergoing allogeneic stem cell transplantation;Blood Cancer Journal;2022-12-19

5. A high hematopoietic cell transplantation comorbidity Index (HCT-CI) does not impair outcomes after non-myeloablative allogeneic stem cell transplantation in acute myeloid leukemia patients 60 years or older;Bone Marrow Transplantation;2022-10-04